Allianz Asset Management »

Revolution Medicines shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.1M 28k 38.81

More positions owned by Allianz Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)
Vici Pptys (VICI)
Applied Materials (AMAT)
Ishares Tr Msci Emg Mkt Etf (EEM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Eli Lilly & Co. (LLY)

View all positions for Allianz Asset Management

Top funds holding Revolution Medicines

Vanguard Group
BlackRock
BlackRock
Farallon Capital Management
Baker Bros. Advisors
Nextech Invest
Paradigm Biocapital Advisors
T. Rowe Price Associates
State Street Corporation
Bellevue Group
Henderson Group
Boxer Capital
Alphabet
Jpmorgan Chase & Co
Casdin Capital

View all funds holding Revolution Medicines